Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery
PHASE3
Evaluate the efficacy of paricalcitol, cholecalciferol, and placebo in the ...
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
PHASE2
The study objective was to evaluate the safety of paricalcitol capsules and...
Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism
PHASE2
The risk of fracture for kidney transplant recipients is 4 times higher tha...
Status
Completed
Location
Mario Negri Institute - Clinical Research Center for Rare Diseases